Cirius Therapeutics' Series A - II Round

Cirius Therapeutics raised a round of funding on August 30, 2018.

Cirius Therapeutics, formerly Octeta Therapeutics, a clinical-stage pharmaceutical company, is developing MSDC-0602K, an insulin sensitizer for the treatment of nonalcoholic steatohepatitis (NASH). MS…

Articles about Cirius Therapeutics' Series A - II Round: